Insider Buying: OneMedNet (NASDAQ:ONMD) Insider Buys 15,000 Shares of Stock

OneMedNet Corporation (NASDAQ:ONMD) insider Jeffrey Yu acquired 15,000 shares of the business’s stock in a transaction that occurred on Thursday, August 21st. The shares were acquired at an average cost of $0.77 per share, for a total transaction of $11,550.00. Following the completion of the acquisition, the insider owned 6,768,910 shares of the company’s stock, valued at $5,212,060.70. This trade represents a 0.22% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Jeffrey Yu also recently made the following trade(s):

• On Thursday, September 25th, Jeffrey Yu bought 1,250 shares of OneMedNet stock. The shares were bought at an average price of $1.03 per share, with a total value of $1,287.50.
• On Wednesday, September 24th, Jeffrey Yu bought 17,200 shares of OneMedNet stock. The shares were bought at an average cost of $1.02 per share, for a total transaction of $17,544.00.
• On Tuesday, September 23rd, Jeffrey Yu purchased 5,700 shares of OneMedNet stock. The stock was bought at an average price of $0.93 per share, for a total transaction of $5,301.00.
• On Monday, September 22nd, Jeffrey Yu purchased 400 shares of OneMedNet stock. The stock was bought at an average cost of $0.95 per share, with a total value of $380.00.
• On Friday, September 19th, Jeffrey Yu acquired 1,250 shares of OneMedNet stock. The shares were bought at an average price of $0.89 per share, with a total value of $1,112.50.
• On Thursday, September 18th, Jeffrey Yu acquired 700 shares of OneMedNet stock. The shares were bought at an average cost of $0.91 per share, for a total transaction of $637.00.
• On Friday, September 5th, Jeffrey Yu bought 2,100 shares of OneMedNet stock. The stock was bought at an average price of $0.86 per share, for a total transaction of $1,806.00.
• On Thursday, September 4th, Jeffrey Yu bought 11,810 shares of OneMedNet stock. The stock was purchased at an average price of $0.87 per share, with a total value of $10,274.70.
• On Wednesday, September 3rd, Jeffrey Yu purchased 11,670 shares of OneMedNet stock. The shares were purchased at an average cost of $0.81 per share, with a total value of $9,452.70.
• On Tuesday, September 2nd, Jeffrey Yu purchased 24,319 shares of OneMedNet stock. The stock was purchased at an average price of $0.85 per share, for a total transaction of $20,671.15.

OneMedNet Stock Down 2.7%

Shares of OneMedNet stock traded down $0.04 on Wednesday, reaching $1.42. The stock had a trading volume of 298,140 shares, compared to its average volume of 762,577. The stock has a market capitalization of $72.43 million, a P/E ratio of -28.40 and a beta of 1.09. The company has a 50 day moving average price of $1.77 and a 200 day moving average price of $0.99. OneMedNet Corporation has a 1 year low of $0.30 and a 1 year high of $4.22.

OneMedNet (NASDAQ:ONMD) last announced its earnings results on Friday, November 14th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.18 million for the quarter.

Institutional Trading of OneMedNet

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Correct Capital Wealth Management purchased a new stake in OneMedNet during the 3rd quarter valued at about $4,910,000. Exencial Wealth Advisors LLC raised its stake in shares of OneMedNet by 141.3% in the third quarter. Exencial Wealth Advisors LLC now owns 3,599,460 shares of the company’s stock worth $3,923,000 after purchasing an additional 2,107,598 shares during the last quarter. Finally, Ashton Thomas Private Wealth LLC purchased a new position in shares of OneMedNet in the third quarter worth about $25,000. Institutional investors and hedge funds own 0.95% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on ONMD. Weiss Ratings reissued a “sell (d-)” rating on shares of OneMedNet in a research report on Tuesday, October 14th. Wall Street Zen upgraded OneMedNet to a “hold” rating in a research note on Friday, September 26th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.

OneMedNet Company Profile

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences.